| Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial AF Hernandez, JB Green, S Janmohamed, RB D'Agostino, CB Granger, ... The Lancet 392 (10157), 1519-1529, 2018 | 1332 | 2018 |
| Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes B Keymeulen, E Vandemeulebroucke, AG Ziegler, C Mathieu, L Kaufman, ... New England journal of medicine 352 (25), 2598-2608, 2005 | 1300 | 2005 |
| Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass B Keymeulen, M Walter, C Mathieu, L Kaufman, F Gorus, R Hilbrands, ... Diabetologia 53, 614-623, 2010 | 349 | 2010 |
| Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study S Charleer, C Mathieu, F Nobels, C De Block, RP Radermecker, ... The Journal of Clinical Endocrinology & Metabolism 103 (3), 1224-1232, 2018 | 176 | 2018 |
| Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study ACG van Baar, F Holleman, L Crenier, R Haidry, C Magee, D Hopkins, ... Gut 69 (2), 295-303, 2020 | 150 | 2020 |
| Conversion from tacrolimus to cyclosporine A for new‐onset diabetes after transplantation: a single‐centre experience in renal transplanted patients and review of the literature L Ghisdal, NB Bouchta, N Broeders, L Crenier, AD Hoang, D Abramowicz, ... Transplant international 21 (2), 146-151, 2008 | 97 | 2008 |
| Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients B Keymeulen, S Candon, S Fafi-Kremer, A Ziegler, M Leruez-Ville, ... Blood, The Journal of the American Society of Hematology 115 (6), 1145-1155, 2010 | 96 | 2010 |
| Prevention of brain demyelination in rats after excessive correction of chronic hyponatremia by serum sodium lowering A Soupart, R Penninckx, L Crenier, A Stenuit, O Perier, G Decaux Kidney international 45 (1), 193-200, 1994 | 89 | 1994 |
| Seasonality in clinical onset of Type 1 diabetes in Belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to … I Weets, L Kaufman, B Van Der Auwera, L Crenier, RPA Rooman, ... Diabetologia 47, 614-621, 2004 | 68 | 2004 |
| Low response to high‐dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitor L Crenier, J Ducobu, JM Des Grottes, J Cerny, C Delaunoit, P Capel British journal of haematology 95 (4), 750-753, 1996 | 56 | 1996 |
| Relationship between time in range, glycemic variability, HbA1c, and complications in adults with type 1 diabetes mellitus A El Malahi, M Van Elsen, S Charleer, E Dirinck, K Ledeganck, ... The Journal of Clinical Endocrinology & Metabolism 107 (2), e570-e581, 2022 | 53 | 2022 |
| 40th EASD Annual Meeting of the European Association for the Study of Diabetes: Munich, Germany, 5–9 September 2004 M Veitenhansl, K Stegner, FX Hierl, C Dieterle, H Feldmeier, B Gutt, ... Diabetologia 47, A1-A464, 2004 | 51 | 2004 |
| Flash glucose monitoring accepted in daily life of children and adolescents with type 1 diabetes and reduction of severe hypoglycemia in real-life use A Messaaoui, S Tenoutasse, L Crenier Diabetes technology & therapeutics 21 (6), 329-335, 2019 | 50 | 2019 |
| Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts P Gillard, Z Ling, C Mathieu, L Crenier, M Lannoo, B Maes, B Roep, ... Transplantation 85 (2), 256-263, 2008 | 36 | 2008 |
| Glucose variability assessed by low blood glucose index is predictive of hypoglycemic events in patients with type 1 diabetes switched to pump therapy L Crenier, C Abou-Elias, B Corvilain Diabetes Care 36 (8), 2148-2153, 2013 | 28 | 2013 |
| In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A* 24 and HLA-B* 18, but not HLA-B* 39, are predictors of impending diabetes with distinct HLA … E Mbunwe, BJ Van der Auwera, I Weets, P Van Crombrugge, L Crenier, ... Diabetologia 56, 1964-1970, 2013 | 25 | 2013 |
| In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A* 24 and HLA-B* 18, but not HLA-B* 39, are predictors of impending diabetes with distinct HLA … E Mbunwe, BJ Van der Auwera, I Weets, P Van Crombrugge, L Crenier, ... Diabetologia 56, 1964-1970, 2013 | 25 | 2013 |
| Poincaré plot quantification for assessing glucose variability from continuous glucose monitoring systems and a new risk marker for hypoglycemia: application to type 1 diabetes … L Crenier Diabetes technology & therapeutics 16 (4), 247-254, 2014 | 23 | 2014 |
| Glucose complexity estimates insulin resistance in either nondiabetic individuals or in type 1 diabetes L Crenier, M Lytrivi, A Van Dalem, B Keymeulen, B Corvilain The Journal of Clinical Endocrinology & Metabolism 101 (4), 1490-1497, 2016 | 20 | 2016 |
| Durable metabolic improvements 2 years after duodenal mucosal resurfacing (DMR) in patients with type 2 diabetes (REVITA-1 Study) ACG van Baar, J Devière, D Hopkins, L Crenier, F Holleman, MPG Neto, ... Diabetes research and clinical practice 184, 109194, 2022 | 19 | 2022 |
